Comparison of Endoscopic Band Ligation Plus 24-hour Versus 72-hour Terlipressin Therapy

NACompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions
Esophageal and Gastric Varices
Interventions
COMBINATION_PRODUCT

banding ligation plus terlipressin infusion

Subjects were randomly allocated to banding ligation plus terlipressin infusion for 24 hours (24-h group) or banding ligation plus terlipressin infusion for 72 hours (72-h group) using a blocked allocation strategy. The 72-h group received the standard treatment with administration of intravenous terlipressin (Glypressin® Ferring Pharmaceuticals) with an initial intravenous bolus of 2 mg (10 ml) and thereafter every 6 hours for a period of 72 hours. Terlipressin was administered blinded after endoscopic treatment and infused as a 5 ml bolus in a pre-prepared syringe. The 24-h group received intravenous terlipressin (Glypressin® Ferring Pharmaceuticals) as an initial intravenous bolus of 2 mg (10 ml) and thereafter every 6 hours for a period of 24 hours.

Trial Locations (1)

44329

Centro Médico Nacional de Occidente, Guadalajara

All Listed Sponsors
lead

Instituto Mexicano del Seguro Social

OTHER_GOV

NCT05331768 - Comparison of Endoscopic Band Ligation Plus 24-hour Versus 72-hour Terlipressin Therapy | Biotech Hunter | Biotech Hunter